{"name": "Advanced In Vitro Cell Technologies",
 "permalink": "advanced-in-vitro-cell-technologies",
 "crunchbase_url": "http://www.crunchbase.com/company/advanced-in-vitro-cell-technologies",
 "homepage_url": "http://www.advancell.net",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2001,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "advancell@advancell.net",
 "phone_number": "34 93 403 45 45",
 "description": "",
 "created_at": "Fri Oct 02 07:33:44 UTC 2009",
 "updated_at": "Mon Mar 15 06:09:45 UTC 2010",
 "overview": "\u003Cp\u003EAdvanced In Vitro Cell Technologies S.L., a biotech nanomedicine company, engages in the development of drugs through the search for new applications for already-known molecules, and services and reagents. It also develops and markets in vitro cell models with a regulatory and/or predictive value. In addition, the company offers research services; safety assessment of cosmetic raw materials and finished products; vitro services for toxicological evaluation and advising; integrated and customized research for absorption, distribution, metabolism, and elimination; skin biology and cosmetics; anti-tumoural activity of compounds; anti-inflammatory activity of new compounds and cell responses to inflammatory stimuli; biocompatibility for evaluating biocompatible materials; CacoReady system, an integral tool designed to optimize time and costs for intestinal absorption evaluation of compounds; CacoGoblet cell model that combines the absorbent qualities of Caco2 cells with a mucosecreting cell line; TransportPlus, a ready-to-use system for in vitro comparative absorption profiling; AdipoReady kit, an in vitro model for studying the toxicity of metabolites derived from the action of cytochrome P-450 isoenzymes in a ready-to-use system; and liver, lung, and human skin microsomes. Advanced In Vitro Cell Technologies S.L. was founded in 2001 and is based in Barcelona, Spain.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       27],
      "assets/images/resized/0006/1489/61489v1-max-150x150.jpg"],
     [[250,
       45],
      "assets/images/resized/0006/1489/61489v1-max-250x250.jpg"],
     [[275,
       50],
      "assets/images/resized/0006/1489/61489v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "CEO",
    "person":
     {"first_name": "Luis",
      "last_name": "Ruiz-Avila",
      "permalink": "luis-ruiz-avila",
      "image": null}},
   {"is_past": false,
    "title": " Director of Financial and Administrative ",
    "person":
     {"first_name": "Juli\u00c3\u00a1n",
      "last_name": "Pe\u00c3\u00b1a",
      "permalink": "julin-pea",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "\u20ac11M",
 "funding_rounds":
  [{"round_code": "unattributed",
    "source_url": "http://advancell.net/site/index.php?pt1=5\u0026pt2=19\u0026pt10=185\u0026ptn=4",
    "source_description": "Advancell captures 11 million euros",
    "raised_amount": 11000000.0,
    "raised_currency_code": "EUR",
    "funded_year": 2007,
    "funded_month": 11,
    "funded_day": 29,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Talde venture capital",
         "permalink": "talde-venture-capital",
         "image":
          {"available_sizes":
            [[[150,
               78],
              "assets/images/resized/0006/1511/61511v3-max-150x150.png"],
             [[169,
               89],
              "assets/images/resized/0006/1511/61511v3-max-250x250.png"],
             [[169,
               89],
              "assets/images/resized/0006/1511/61511v3-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition":
  {"price_amount": 3340000.0,
   "price_currency_code": "USD",
   "term_code": null,
   "source_url": "",
   "source_description": "Cap Funding Report",
   "acquired_year": 2008,
   "acquired_month": 7,
   "acquired_day": 11,
   "acquiring_company":
    {"name": "Indukern",
     "permalink": "indukern",
     "image":
      {"available_sizes":
        [[[150,
           90],
          "assets/images/resized/0006/1490/61490v1-max-150x150.png"],
         [[208,
           126],
          "assets/images/resized/0006/1490/61490v1-max-250x250.png"],
         [[208,
           126],
          "assets/images/resized/0006/1490/61490v1-max-450x450.png"]],
       "attribution": null}}},
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "Parc Cientific de Barcelona",
    "address2": "Baldiri Reixach, 10-12",
    "zip_code": "08028",
    "city": "Barcelona",
    "state_code": null,
    "country_code": "ESP",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}